AAO-HNS GUIDELINES Bundle (free trial)

Immunotherapy for Inhalant Allergy

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1516464

Contents of this Issue

Navigation

Page 12 of 15

13 Offer or refer for AIT Relative contraindications to AIT Shared-decision making with patient and other specialists about whether to proceed with AIT Repeat allergy testing Do not repeat testing Option to treat with limited number of allergens Continue ≥3 years while monitoring treatment response End End Stop Do not proceed with AIT KAS 1 KAS 8 KAS 2B KAS 10 KAS 3 Patient preference for immunomodulation? Beta-blocker, history of anaphylaxis, systemic immunosuppression, or eosinophilic esophagitis (SLIT only) Signs or symptoms of asthma or uncontrolled asthma? Clinician can diagnose and manage anaphylaxis? Patient benefit of AIT? Decision to proceed with AIT? YES YES YES YES YES YES NO NO NO NO NO KAS 12 KAS 12

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Immunotherapy for Inhalant Allergy